PortfoliosLab logo

Can-Fite BioPharma Ltd. (CANF)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS13471N2018
CUSIP13471N201
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.91
Year Range$0.83 - $2.34
EMA (50)$0.94
EMA (200)$1.28
Average Volume$117.80K
Market Capitalization$24.79M

CANFShare Price Chart


Chart placeholderClick Calculate to get results

CANFPerformance

The chart shows the growth of $10,000 invested in Can-Fite BioPharma Ltd. on Nov 12, 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $111 for a total return of roughly -98.89%. All prices are adjusted for splits and dividends.


CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M1.31%-6.21%
YTD-29.32%-18.17%
6M-33.45%-17.47%
1Y-59.48%-8.89%
5Y-49.16%10.04%
10Y-39.60%10.67%

CANFMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CANFSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Can-Fite BioPharma Ltd. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFDividend History

Can-Fite BioPharma Ltd. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM2021202020192018201720162015201420132012
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.17$0.00

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.19%0.00%

CANFDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

CANFWorst Drawdowns

The table below shows the maximum drawdowns of the Can-Fite BioPharma Ltd.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Can-Fite BioPharma Ltd. is 99.36%, recorded on May 12, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.36%Dec 24, 20132110May 12, 2022
-40%Nov 12, 201248Sep 10, 201313Oct 1, 201361
-20.11%Oct 21, 20138Oct 30, 201313Nov 18, 201321
-19.97%Dec 2, 20131Dec 2, 201315Dec 23, 201316
-14.08%Oct 3, 20135Oct 9, 20136Oct 17, 201311

CANFVolatility Chart

Current Can-Fite BioPharma Ltd. volatility is 40.02%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CANF (Can-Fite BioPharma Ltd.)
Benchmark (^GSPC)

Portfolios with Can-Fite BioPharma Ltd.


Loading data...